Physician

Abeera A Khan, M.D

According to 2025 Medicare claims, Abeera Khan, M.D (NPI: 1518377258) practices internal medicine in the Atlantic City-Hammonton, NJ market, with the plurality of this provider's patient population coming from Atlantic, NJ. This provider's primary affiliated billing organization is ATLANTICARE PHYSICIAN GROUP PA (NPI: 1093829608; TIN: 020701782) and primary practice location at 08234-9998. Khan is affiliated with the AtlantiCare Health Solutions, Inc. (ACO ID: A4516), participating under the MSSP model.

Khan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 227 traditional Medicare patients, billed 664 HCPCS/CPT codes, and received $46,904 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 3,230 prescription claims across 458 beneficiaries totaling $1,800,386 in drug costs, led by Ozempic (Semaglutide). DME data shows 360 claims. Open Payments data shows 50 records totaling $862. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $4,746 to $1,800,386. For DME billing, reported payments moved sharply higher in recent years, from $11,540 to $144,733.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	186	441	$38,740
2021	296	629	$57,157
2022	291	604	$53,097
2023	337	776	$59,462
2024	227	664	$46,904

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	11	14	$4,746
2020	193	940	$424,915
2021	363	2,606	$1,517,762
2022	475	3,538	$2,125,296
2023	527	4,155	$2,743,081
2024	458	3,230	$1,800,386

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	32	101	$9,993
2021	118	348	$34,906
2022	156	637	$87,100
2023	130	714	$122,708
2024	127	360	$141,446

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	33	38	$145
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	170	288	$100
95251	Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	54	96	$27
83036	Hemoglobin a1c level	40	48	$9
82962	Blood glucose (sugar) test performed by hand-held instrument	50	56	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	236	14,066	$454,176
Jardiance	Empagliflozin	259	17,768	$333,312
Trulicity	Dulaglutide	135	7,730	$251,441
Farxiga	Dapagliflozin Propanediol	55	4,837	$88,194
Mounjaro	Tirzepatide	66	2,276	$77,945

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	76	256	$133,507
E2103	Non-adjunctive, non-implanted continuous glucose monitor or receiver	N	18	18	$3,799
A4224	Supplies for maintenance of insulin infusion catheter, per week	N	N/R	12	$2,651
A4225	Supplies for external insulin infusion pump, syringe type cartridge, sterile, each	N	N/R	13	$933
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	20	40	$528

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	50	$862	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abeera A. Khan, M.D?

Tedicare shows public-source Medicare data for Abeera A. Khan, M.D (NPI 1518377258), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abeera A. Khan, M.D have ACO affiliation data?

Abeera A. Khan, M.D is shown with ACO affiliation data for AtlantiCare Health Solutions, Inc. (MSSP, ACO ID A4516).

What billing organization is linked to Abeera A. Khan, M.D?

Abeera A. Khan, M.D is linked to ATLANTICARE PHYSICIAN GROUP PA (billing NPI 1093829608) in the available physician profile data.

Does Abeera A. Khan, M.D have Open Payments data?

Abeera A. Khan, M.D has 50 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.